Adagene (ADAG) has a profit margin of -764.28%, below the Healthcare sector average of 15.29%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
As of the most recent data (December 2025), ADAG shows a profit margin of -764.28%. That compares with -105.72% in the prior-year period — down 622.9% year over year. That is below the Healthcare sector average of 15.29%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ADAG's profit margin is now -764.28% (was -105.72%) — a 622.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Adagene is outperforming or lagging.
The Healthcare sector average profit margin is about 15.29%. Adagene is at -764.28%, which is lower that average. That is roughly 5097.6% below the sector mean. Use the comparison chart on this page to see how ADAG stacks up against individual peers as well.
That compares with -105.72% in the prior-year period — down 622.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Adagene with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Adagene's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -764.28%) with ownership activity and broader fundamentals.